92 research outputs found
Neuropathic pain
Background Chronic neuropathic pain is a common occurrence, its prevalence ranges from 7 to 10% of the total population. Currently, the only official document that includes neuropathic pain is the International Classification of Headaches Disorders (ICHD-3), in which this type of pain is associated with traumatic brain injury and neuralgia. Until now, there has been no generally accepted terminology and classification of chronic neuropathic pain.Objective To provide the current terminology, classification and additional characteristics of neuropathic chronic pain.Results The review of modern terminology and classification of neuropathic chronic pain describes the terms included in the concept of chronic peripheral and central neuropathic pain, identifies pain subtypes, as well as its additional characteristics such as the intensity of neuropathic pain, the severity of suffering and disability.Conclusions Thus, the presented recent classification of chronic neuropathic pain is an exhaustive list of the most common neuropathic pain syndromes. The inclusion of classification into clinical practice will help to draw attention to the problem of treatment of chronic neuropathic pain by WHO members, carrying out epidemiological studies and making a correct diagnosis, and therefore the appointment of adequate treatment methods
Preparation and properties of nanostructured magnetic hollow microspheres: experiment and simulation
Π‘Π΅Π½ΡΠΎΡΠ½ΡΠ΅ ΡΠ΅Π½ΠΎΡΠΈΠΏΡ Ρ ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ Π±ΠΎΠ»ΠΈ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ², ΠΏΠ΅ΡΠ΅ΠΆΠΈΠ²ΡΠΈΡ ΠΊΡΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΡΠΎΡΡΠΎΡΠ½ΠΈΠ΅: ΠΏΡΠΎΡΠΏΠ΅ΠΊΡΠΈΠ²Π½ΠΎΠ΅ Π½Π°Π±Π»ΡΠ΄Π°ΡΠ΅Π»ΡΠ½ΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅
ΠΠΠ’Π£ΠΠΠ¬ΠΠΠ‘Π’Π¬: ΠΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ ΡΠ΅Π½ΡΠΎΡΠ½ΡΡ
ΡΠ΅Π½ΠΎΡΠΈΠΏΠΎΠ², ΠΊΠΎΡΠΎΡΡΠ΅ ΠΎΡΡΠ°ΠΆΠ°ΡΡ Π»Π΅ΠΆΠ°ΡΠΈΠ΅ Π²Β ΠΈΡ
ΠΎΡΠ½ΠΎΠ²Π΅ Π±ΠΎΠ»Π΅Π²ΡΠ΅ ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΡ, Π°ΠΊΡΡΠ°Π»ΡΠ½ΠΎ Π΄Π»Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΡΒ Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ Π±ΠΎΠ»ΡΡ, ΠΏΠ΅ΡΠ΅ΠΆΠΈΠ²ΡΠΈΡ
ΠΊΡΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΡΠΎΡΡΠΎΡΠ½ΠΈΠ΅. Π¦ΠΠΠ¬ ΠΠ‘Π‘ΠΠΠΠΠΠΠΠΠ―: ΠΡΠ΅Π½ΠΈΡΡ ΠΈΠ½ΡΠ΅Π½ΡΠΈΠ²Π½ΠΎΡΡΡ, Π»ΠΎΠΊΠ°Π»ΠΈΠ·Π°ΡΠΈΡ ΠΈΒ ΡΠ΅Π½ΡΠΎΡΠ½ΡΠ΅ ΡΠ΅Π½ΠΎΡΠΈΠΏΡ Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ Π±ΠΎΠ»ΠΈ ΡΒ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ², ΠΏΠ΅ΡΠ΅Π½Π΅ΡΡΠΈΡ
ΠΊΡΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΡΠΎΡΡΠΎΡΠ½ΠΈΠ΅. ΠΠΠ’ΠΠ ΠΠΠΠ« Π ΠΠΠ’ΠΠΠ«: Π ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Π±ΡΠ»ΠΎ Π²ΠΊΠ»ΡΡΠ΅Π½ΠΎ 99Β ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ², ΠΏΠ΅ΡΠ΅Π½Π΅ΡΡΠΈΡ
ΠΊΡΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΡΠΎΡΡΠΎΡΠ½ΠΈΠ΅. ΠΡΠΈΡΠ΅ΡΠΈΡΠΌΠΈ Π²ΠΊΠ»ΡΡΠ΅Π½ΠΈΡ ΡΠ²Π»ΡΠ»ΠΈΡΡ: Π²ΠΎΠ·ΡΠ°ΡΡ 18β75Β Π»Π΅Ρ, Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΡ ΠΏΡΠ΅Π±ΡΠ²Π°Π½ΠΈΡ Π²Β ΠΎΡΠ΄Π΅Π»Π΅Π½ΠΈΠΈ ΡΠ΅Π°Π½ΠΈΠΌΠ°ΡΠΈΠΈ ΠΈΒ ΠΈΠ½ΡΠ΅Π½ΡΠΈΠ²Π½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ (ΠΠ ΠΠ’) >Β 3Β Π΄Π½Π΅ΠΉ, Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΡ ΠΈΡΠΊΡΡΡΡΠ²Π΅Π½Π½ΠΎΠΉ Π²Π΅Π½ΡΠΈΠ»ΡΡΠΈΠΈ Π»Π΅Π³ΠΊΠΈΡ
(ΠΠΠ) >Β 48Β Ρ, ΠΎΡΠ΅Π½ΠΊΠ° Π½Π° ΠΌΠΎΠΌΠ΅Π½Ρ ΠΏΠΎΡΡΡΠΏΠ»Π΅Π½ΠΈΡ ΠΏΠΎ ΡΠΊΠ°Π»Π΅ Acute Physiology And Chronic Health EvaluationΒ II (APACHEΒ II) β₯Β 7Β Π±Π°Π»Π»ΠΎΠ², ΠΏΠΎΠ»ΡΡΠ΅Π½ΠΈΠ΅ ΠΈΠ½ΡΠΎΡΠΌΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠ³ΠΎ ΡΠΎΠ³Π»Π°ΡΠΈΡ. ΠΠΎΠΊΠ°Π»ΠΈΠ·Π°ΡΠΈΡ, ΠΈΠ½ΡΠ΅Π½ΡΠΈΠ²Π½ΠΎΡΡΡ ΠΈΒ ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΠ΅ Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΡΡΠΈΠΊΠΈ Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ (6Β ΠΌΠ΅Ρ.) Π±ΠΎΠ»ΠΈ, ΡΠ²ΡΠ·Π°Π½Π½ΠΎΠΉ ΡΒ ΠΏΡΠ΅Π±ΡΠ²Π°Π½ΠΈΠ΅ΠΌ Π²Β ΠΠ ΠΠ’, ΠΎΡΠ΅Π½ΠΈΠ²Π°Π»ΠΈ ΠΏΡΠΈ ΠΏΠΎΠΌΠΎΡΠΈ ΠΊΡΠ°ΡΠΊΠΎΠ³ΠΎ ΠΎΠΏΡΠΎΡΠ½ΠΈΠΊΠ° Π±ΠΎΠ»ΠΈ, ΠΎΠΏΡΠΎΡΠ½ΠΈΠΊΠ° PainDetect, Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΠΎΡΡΡ ΡΡΠ΅Π²ΠΎΠ³ΠΈ ΠΈΒ Π΄Π΅ΠΏΡΠ΅ΡΡΠΈΠΈΒ β ΠΏΠΎ ΡΠΊΠ°Π»Π΅ Hospital Anxiety and Depression Scale (HADS). ΠΡΠ΅ΠΌ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠ°ΠΌ ΠΏΠ΅ΡΠ΅Π΄ Π²ΡΠΏΠΈΡΠΊΠΎΠΉ Π²ΡΠΏΠΎΠ»Π½Π΅Π½ΠΎ ΡΠ΅ΡΠΌΠ°Π»ΡΠ½ΠΎΠ΅ ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΠ΅ ΡΠ΅Π½ΡΠΎΡΠ½ΠΎΠ΅ ΡΠ΅ΡΡΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ (ΠΠ‘Π’) ΡΒ ΠΎΡΠ΅Π½ΠΊΠΎΠΉ ΠΏΠΎΡΠΎΠ³ΠΎΠ² ΠΎΠ±Π½Π°ΡΡΠΆΠ΅Π½ΠΈΡ Ρ
ΠΎΠ»ΠΎΠ΄Π° ΠΈΒ ΠΎΠ±Π½Π°ΡΡΠΆΠ΅Π½ΠΈΡ ΡΠ΅ΠΏΠ»Π°, ΠΏΠ°ΡΠ°Π΄ΠΎΠΊΡΠ°Π»ΡΠ½ΡΡ
ΡΠ΅ΠΏΠ»ΠΎΠ²ΡΡ
ΠΎΡΡΡΠ΅Π½ΠΈΠΉ, ΠΏΠΎΡΠΎΠ³ΠΎΠ² Ρ
ΠΎΠ»ΠΎΠ΄ΠΎΠ²ΠΎΠΉ ΠΈΒ ΡΠ΅ΠΏΠ»ΠΎΠ²ΠΎΠΉ Π±ΠΎΠ»ΠΈ, ΡΡΠ»ΠΎΠ²Π½ΠΎΠΉ ΠΌΠΎΠ΄ΡΠ»ΡΡΠΈΠΈ Π±ΠΎΠ»ΠΈ. Π ΠΠΠ£ΠΠ¬Π’ΠΠ’Π«: Π§Π΅ΡΠ΅Π· 6Β ΠΌΠ΅Ρ. Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΉ Π±ΠΎΠ»Π΅Π²ΠΎΠΉ ΡΠΈΠ½Π΄ΡΠΎΠΌ ΡΡΠΎΡΠΌΠΈΡΠΎΠ²Π°Π»ΡΡ ΡΒ 59Β % ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ². ΠΡΠ»ΠΈ ΠΏΠΎΠ»ΡΡΠ΅Π½Ρ Π΄Π°Π½Π½ΡΠ΅ ΠΎΠ± ΠΈΠ½ΡΠ΅Π½ΡΠΈΠ²Π½ΠΎΡΡΠΈ, ΠΎΒ Π»ΠΎΠΊΠ°Π»ΠΈΠ·Π°ΡΠΈΠΈ, ΡΡΠ΅ΠΏΠ΅Π½ΠΈ Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΠΎΡΡΠΈ Π½Π΅ΠΉΡΠΎΠΏΠ°ΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΈΒ Π΄ΠΈΡΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎΠ³ΠΎ ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½ΡΠ° Π±ΠΎΠ»ΠΈ. ΠΡΠΈ ΠΎΡΠ΅Π½ΠΊΠ΅ ΡΠ΅ΡΠΌΠ°Π»ΡΠ½ΡΡ
ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ ΠΠ‘Π’ ΡΒ ΠΏΠΎΠΌΠΎΡΡΡ ΠΈΠ΅ΡΠ°ΡΡ
ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΊΠ»Π°ΡΡΠ΅ΡΠ½ΠΎΠ³ΠΎ Π°Π½Π°Π»ΠΈΠ·Π° Π²ΡΡΠ²Π»Π΅Π½Ρ ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½Π°Ρ ΡΠ²ΡΠ·Ρ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠΉ ΡΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΈΒ Π΄ΠΈΠ½Π°ΠΌΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ ΡΠ΅ΡΠΌΠ°Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠ΅Π½ΡΠΎΡΠ½ΠΎΠ³ΠΎ ΡΠ΅ΡΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ, ΡΠΎΡΠΌΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ Β«ΡΠ°Π·Π΄ΡΠ°ΠΆΠ΅Π½Π½ΠΎΠ³ΠΎΒ» ΠΈΒ Β«Π΄Π΅Π°ΡΡΠ΅ΡΠ΅Π½ΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠ³ΠΎΒ» ΡΠ΅Π½ΡΠΎΡΠ½ΠΎΠ³ΠΎ ΡΠ΅Π½ΠΎΡΠΈΠΏΠ° Π²Β Π·Π°Π²ΠΈΡΠΈΠΌΠΎΡΡΠΈ ΠΎΡ Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ ΠΠΠ, ΠΏΡΠ΅Π±ΡΠ²Π°Π½ΠΈΡ Π²Β ΠΎΡΠ΄Π΅Π»Π΅Π½ΠΈΠΈ ΠΈΠ½ΡΠ΅Π½ΡΠΈΠ²Π½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΠΈΒ ΠΎΡΠ΅Π½ΠΊΠΈ ΠΏΠΎ ΡΠΊΠ°Π»Π΅ Sequential Organ Failure Assessment (SOFA). ΠΠ«ΠΠΠΠ«: ΠΡΡΠ²Π»Π΅Π½ΠΈΠ΅ ΡΠ΅Π½ΡΠΎΡΠ½ΡΡ
ΡΠ΅Π½ΠΎΡΠΈΠΏΠΎΠ² ΠΏΠΎΠ·Π²ΠΎΠ»ΡΠ΅Ρ ΠΎΠΏΡΠ΅Π΄Π΅Π»ΠΈΡΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΡΒ Π΄ΠΈΡΡΡΠ½ΠΊΡΠΈΠ΅ΠΉ Π²ΠΎΠ»ΠΎΠΊΠΎΠ½ ΠΌΠ°Π»ΠΎΠ³ΠΎ Π΄ΠΈΠ°ΠΌΠ΅ΡΡΠ°, Π½Π°ΡΡΡΠ΅Π½ΠΈΠ΅ΠΌ ΡΠ½Π΄ΠΎΠ³Π΅Π½Π½ΡΡ
ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΠΎΠ² ΠΊΠΎΠ½ΡΡΠΎΠ»Ρ Π±ΠΎΠ»ΠΈ, ΡΡΠΎ ΠΏΠΎΠ·Π²ΠΎΠ»ΠΈΡ ΠΏΠΎΠ΄ΠΎΠ±ΡΠ°ΡΡ ΠΈΠ½Π΄ΠΈΠ²ΠΈΠ΄ΡΠ°Π»ΡΠ½ΡΡ ΠΏΡΠΎΠ³ΡΠ°ΠΌΠΌΡ ΠΎΠ±Π»Π΅Π³ΡΠ΅Π½ΠΈΡ Π±ΠΎΠ»ΠΈ
CHANGES IN THE LEVEL OF NT-proBNP AND MEAN PULMONARY ARTERY PRESSURE FOLLOWING BRONCHOPLASTIC LOBECTOMY OR PNEUMONECTOMY AS MARKERS OF RIGHT VENTRICULAR DYSFUNCTION
Background There are scanty data of right ventricular dysfunction markers after major pulmonary resection.Objective To study the changes of plasma level of N-terminal pro-brain natriuretic peptide (NT-proBNP) and itsΒ association with pulmonary artery pressure (PAP) as markers of right ventricular dysfunction in patientsΒ who underwent bronchoplastic lobectomy or pneumonectomy.Material and Methods The study population consisted of 36 patients aged 40β65 who underwent majorΒ pulmonary resectionΒ for lung cancer in 2016β2018. Patients were stratified into two groups according to the type of surgicalΒ procedure: bronchoplastic lobectomy, the main group (n = 19), and pneumonectomy, control group (n = 17).Β They were then analyzed for plasma NT-proBNP concentration, operative time, blood loss, intraoperativeΒ fluid administration, intraoperative urine output, and mean PAP level before and after an operation.Results The mean PAP level correlated positively with the plasma NT-proBNP concentration in the pneumonectomyΒ group (Pearson r = 0.916754; p < 0.001). This correlation was no evident in the subset of patientsΒ undergoing bronchoplastic lobectomy at the same determination point (Pearson r = 0.234741; p = 0.330).Conclusion The mean PAP increased significantly after pneumonectomy and is closely correlated with plasmaΒ NTproBNP concentration. These findings support the conclusion that bronchoplasty is preferable overΒ pneumonectomy for lung cancer patients
The certification of the activity concentration of the radionuclides 137Cs, 90Sr and 40K in wild berries: IRMM-426
This report describes the production of CRM IRMM-426, a dried bilberry material certified for the radionuclide activity concentrations of 137Cs, 90Sr and 40K. The material was produced following ISO Guide 34:2009.
Bilberry samples were collected in a woodland region of so-called βstrontium hot spotsβ close to the Chernobyl reactor site. The samples were air-dried at the sampling site before transport to IRMM, where the raw material was oven-dried, cryo-milled, sieved, homogenised and bottled. The bottled material was sterilised by gamma-irradiation.
Between-unit homogeneity was quantified and stability during dispatch and storage were assessed in accordance with ISO Guide 35:2006.
The material was characterised by an intercomparison among laboratories of demonstrated competence and adhering to ISO/IEC 17025. Technically invalid results were removed but no outlier was eliminated on statistical grounds only.
Uncertainties of the certified values were calculated in compliance with the Guide to the Expression of Uncertainty in Measurement (GUM) and include uncertainties related to possible inhomogeneity and instability and to characterisation.
The material is intended for the assessment of method performance and quality control. As any reference material, it can also be used for control charts or validation studies. The CRM is available in amber glass jars containing about 100 g of dried bilberry powder. The minimum amount of sample to be used for analysis is 50 g for 90Sr and 18 g for 137Cs and 40K.JRC.D.2-Standards for Innovation and sustainable Developmen
Jastrow-type calculations of one-nucleon removal reactions on open - shell nuclei
Single-particle overlap functions and spectroscopic factors are calculated on
the basis of Jastrow-type one-body density matrices of open-shell nuclei
constructed by using a factor cluster expansion. The calculations use the
relationship between the overlap functions corresponding to bound states of the
-particle system and the one-body density matrix for the ground state of
the -particle system. In this work we extend our previous analyses of
reactions on closed-shell nuclei by using the resulting overlap functions for
the description of the cross sections of reactions on the open -
shell nuclei Mg, Si and S and of S
reaction. The relative role of both shell structure and short-range
correlations incorporated in the correlation approach on the spectroscopic
factors and the reaction cross sections is pointed out.Comment: 11 pages, 5 figures, to be published in Phys. Rev.
Bioinspired Magneto-optical Bacteria
βTwo-in-oneβ magneto-optical bacteria have been produced using the probiotic Lactobacillus fermentum for the first time. We took advantage of two features of bacteria to synthesize this novel and bifunctional nanostructure: their metal-reducing properties, to produce gold nanoparticles, and their capacity to incorporate iron oxide nanoparticles at their external surface. The magneto-optical bacteria survive the process and behave as a magnet at room temperature.This work was funded by Biosearch S.A. (POSTBIO project-Agency for Innovation and Development of Andalucia IDEA) and by MINECO and FEDER (project CTQ2012-32236)
ΠΠΎΠ΄Π΅Π»Ρ ΠΏΡΠΎΠ³Π½ΠΎΠ·ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΏΠΎΡΠ»Π΅ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠΉ ΠΏΠ½Π΅Π²ΠΌΠΎΠ½ΠΈΠΈ Π² Π°Π±Π΄ΠΎΠΌΠΈΠ½Π°Π»ΡΠ½ΠΎΠΉ Ρ ΠΈΡΡΡΠ³ΠΈΠΈ: ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΡ Π½Π°Π±Π»ΡΠ΄Π°ΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΠΌΠ½ΠΎΠ³ΠΎΡΠ΅Π½ΡΡΠΎΠ²ΠΎΠ³ΠΎ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ
ΠΠΠ’Π£ΠΠΠ¬ΠΠΠ‘Π’Π¬: ΠΠ΅Π΄ΡΡΠ΅Π΅ ΠΌΠ΅ΡΡΠΎ Π²Β ΡΡΡΡΠΊΡΡΡΠ΅ ΠΏΠΎΡΠ»Π΅ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΡΡ
ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠΉ Π·Π°Π½ΠΈΠΌΠ°Π΅Ρ ΠΏΠΎΡΠ»Π΅ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½Π°Ρ ΠΏΠ½Π΅Π²ΠΌΠΎΠ½ΠΈΡ. Π£ΡΠΈΡΡΠ²Π°Ρ ΡΠ°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½Π½ΠΎΡΡΡ ΠΏΠΎΡΠ»Π΅ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠΉ ΠΏΠ½Π΅Π²ΠΌΠΎΠ½ΠΈΠΈ ΠΈΒ ΡΠΎΡΡ ΡΠΈΡΠ»Π° Ρ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΡΠΎΡΠ΅Π΄ΡΡ, ΠΏΡΠΎΠ³Π½ΠΎΠ·ΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ Π΅Π΅ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΡΠ²Π»ΡΠ΅ΡΡΡ Π°ΠΊΡΡΠ°Π»ΡΠ½ΠΎΠΉ Π·Π°Π΄Π°ΡΠ΅ΠΉ, ΠΏΠΎΠ·Π²ΠΎΠ»ΡΡΡΠ΅ΠΉ ΠΏΡΠΈΠ½ΡΡΡ ΠΌΠ΅ΡΡ ΠΏΠΎ ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΡ ΡΠ°ΡΡΠΎΡΡ Π΅Π΅ Π²ΠΎΠ·Π½ΠΈΠΊΠ½ΠΎΠ²Π΅Π½ΠΈΡ, ΠΏΡΡΠ΅ΠΌ ΠΎΠΏΡΠΈΠΌΠΈΠ·Π°ΡΠΈΠΈ ΠΏΠ΅ΡΠΈΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠ³ΠΎ ΠΏΠ΅ΡΠΈΠΎΠ΄Π°. ΠΠ΅ΡΠΌΠΎΡΡΡ Π½Π° ΡΠ²ΠΎΡ ΡΠ΅Π½Π½ΠΎΡΡΡ, ΡΡΡΠ΅ΡΡΠ²ΡΡΡΠΈΠ΅ ΡΠΊΠ°Π»Ρ ΠΏΡΠΎΠ³Π½ΠΎΠ·ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΏΠΎΡΠ»Π΅ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠΉ ΠΏΠ½Π΅Π²ΠΌΠΎΠ½ΠΈΠΈ Π½Π΅ ΠΎΠ±Π΅ΡΠΏΠ΅ΡΠΈΠ²Π°ΡΡ ΠΎΡΠ΅ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΡ
ΡΠΏΠ΅ΡΠΈΠ°Π»ΠΈΡΡΠΎΠ² Π½Π°Π΄Π΅ΠΆΠ½ΡΠΌ ΠΈΒ ΠΏΠΎΡΡΠΎΡΠ½Π½ΡΠΌ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ, ΡΒ ΠΏΠΎΠΌΠΎΡΡΡ ΠΊΠΎΡΠΎΡΠΎΠ³ΠΎ ΠΌΠΎΠΆΠ½ΠΎ ΡΡΡΠ°ΡΠΈΡΠΈΡΠΈΡΠΎΠ²Π°ΡΡ ΡΠΈΡΠΊ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΏΠΎΡΠ»Π΅ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠΉ ΠΏΠ½Π΅Π²ΠΌΠΎΠ½ΠΈΠΈ Π²Β Π½Π°ΡΠ΅ΠΉ ΠΏΠΎΠΏΡΠ»ΡΡΠΈΠΈ. Π¦ΠΠΠ¬ ΠΠ‘Π‘ΠΠΠΠΠΠΠΠΠ―: ΡΠ°Π·ΡΠ°Π±ΠΎΡΠΊΠ° ΠΌΠΎΠ΄Π΅Π»ΠΈ ΠΏΡΠΎΠ³Π½ΠΎΠ·ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΏΠΎΡΠ»Π΅ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠΉ ΠΏΠ½Π΅Π²ΠΌΠΎΠ½ΠΈΠΈ Π½Π° ΠΎΡΠ½ΠΎΠ²Π΅ Π²ΡΡΠ²Π»Π΅Π½ΠΈΡ ΡΠ°ΠΊΡΠΎΡΠΎΠ² ΡΠΈΡΠΊΠ° Π΅Π΅ ΡΠ°Π·Π²ΠΈΡΠΈΡ. ΠΠΠ’ΠΠ ΠΠΠΠ« Π ΠΠΠ’ΠΠΠ«: ΠΠ½ΠΎΠ³ΠΎΡΠ΅Π½ΡΡΠΎΠ²ΠΎΠ΅ ΠΏΡΠΎΡΠΏΠ΅ΠΊΡΠΈΠ²Π½ΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅, 6844Β ΠΏΠ°ΡΠΈΠ΅Π½ΡΠ° ΡΡΠ°ΡΡΠ΅ 18Β Π»Π΅Ρ, ΠΏΠΎΠ΄Π²Π΅ΡΠ³Π°ΡΡΠΈΠ΅ΡΡ ΠΏΠ»Π°Π½ΠΎΠ²ΡΠΌ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠ²Π½ΡΠΌ Π²ΠΌΠ΅ΡΠ°ΡΠ΅Π»ΡΡΡΠ²Π°ΠΌ Π½Π° ΠΎΡΠ³Π°Π½Π°Ρ
Π±ΡΡΡΠ½ΠΎΠΉ ΠΏΠΎΠ»ΠΎΡΡΠΈ. ΠΡΠ΅Π½ΠΈΠ²Π°Π»ΠΈ 30-Π΄Π½Π΅Π²Π½ΡΡ Π»Π΅ΡΠ°Π»ΡΠ½ΠΎΡΡΡ ΠΈΒ ΠΏΠΎΡΠ»Π΅ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΡΡ ΠΏΠ½Π΅Π²ΠΌΠΎΠ½ΠΈΡ. ΠΠ° ΠΏΠ΅ΡΠ²ΠΎΠΌ ΡΡΠ°ΠΏΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΎΡΡ ΡΡΠ°Π²Π½Π΅Π½ΠΈΠ΅ ΠΌΠ΅ΠΆΠ΄Ρ Π³ΡΡΠΏΠΏΠΎΠΉ ΡΒ ΠΏΠ½Π΅Π²ΠΌΠΎΠ½ΠΈΠ΅ΠΉ ΠΈΒ Π³ΡΡΠΏΠΏΠΎΠΉ Π±Π΅Π· ΠΏΠ½Π΅Π²ΠΌΠΎΠ½ΠΈΠΈ ΠΈΡΡ
ΠΎΠ΄Π½ΡΡ
Π΄Π°Π½Π½ΡΡ
ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ², Π°Β ΡΠ°ΠΊΠΆΠ΅ ΡΠ°ΠΊΡΠΎΡΠΎΠ², ΡΠ²ΡΠ·Π°Π½Π½ΡΡ
ΡΒ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠ΅ΠΉ ΠΈΒ Π°Π½Π΅ΡΡΠ΅Π·ΠΈΠ΅ΠΉ. ΠΠ° Π²ΡΠΎΡΠΎΠΌ ΡΡΠ°ΠΏΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΡΡ Π»ΠΎΠ³ΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈΠΉ ΡΠ΅Π³ΡΠ΅ΡΡΠΈΠΎΠ½Π½ΡΠΉ Π°Π½Π°Π»ΠΈΠ· Π΄Π»Ρ ΠΎΡΠ΅Π½ΠΊΠΈ Π²ΠΊΠ»Π°Π΄Π° ΡΠ°ΠΊΡΠΎΡΠΎΠ² Π²Β ΡΠ°Π·Π²ΠΈΡΠΈΠ΅ ΠΏΠΎΡΠ»Π΅ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠΉ ΠΏΠ½Π΅Π²ΠΌΠΎΠ½ΠΈΠΈ. ΠΠ° ΡΡΠ΅ΡΡΠ΅ΠΌ ΡΡΠ°ΠΏΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ Π²ΡΠΏΠΎΠ»Π½ΡΠ»ΠΎΡΡ ΠΏΠΎΡΡΡΠΎΠ΅Π½ΠΈΠ΅ ΠΌΠΎΠ΄Π΅Π»ΠΈ ΠΏΡΠΎΠ³Π½ΠΎΠ·ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΏΠΎΡΠ»Π΅ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠΉ ΠΏΠ½Π΅Π²ΠΌΠΎΠ½ΠΈΠΈ ΠΏΠΎ Π΄Π°Π½Π½ΡΠΌ ΠΌΠ½ΠΎΠ³ΠΎΠΌΠ΅ΡΠ½ΠΎΠ³ΠΎ Π»ΠΎΠ³ΠΈΡΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠ΅Π³ΡΠ΅ΡΡΠΈΠΎΠ½Π½ΠΎΠ³ΠΎ Π°Π½Π°Π»ΠΈΠ·Π°. ΠΠ° Π·Π°ΠΊΠ»ΡΡΠΈΡΠ΅Π»ΡΠ½ΠΎΠΌ ΡΡΠ°ΠΏΠ΅ ΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄ΠΈΠ»ΠΎΡΡ ΡΡΠ°Π²Π½Π΅Π½ΠΈΠ΅ ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΠΎΠΉ ΠΌΠΎΠ΄Π΅Π»ΠΈ ΡΒ ΠΌΠΎΠ΄Π΅Π»ΡΠΌΠΈ ΠΏΡΠΎΠ³Π½ΠΎΠ·ΠΈΡΠΎΠ²Π°Π½ΠΈΡ Π΄ΡΡΠ³ΠΈΡ
Π°Π²ΡΠΎΡΠΎΠ², Π²ΡΡΡΠ΅ΡΠ°ΡΡΠΈΡ
ΡΡ Π²Β ΠΌΠΈΡΠΎΠ²ΠΎΠΉ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΠ΅. Π ΠΠΠ£ΠΠ¬Π’ΠΠ’Π«: ΠΠ½Π΅Π²ΠΌΠΎΠ½ΠΈΡ Π²ΡΡΠ²Π»Π΅Π½Π° ΡΒ 53Β ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² (0,77Β %). ΠΠ΅ΡΠ°Π»ΡΠ½ΡΠΉ ΠΈΡΡ
ΠΎΠ΄ Π½Π°Π±Π»ΡΠ΄Π°Π»ΡΡ ΡΒ 39Β ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ²: ΡΒ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΡΒ ΠΏΠ½Π΅Π²ΠΌΠΎΠ½ΠΈΠ΅ΠΉ Π²Β 15Β ΡΠ»ΡΡΠ°ΡΡ
(28,3Β %), Π°Β Π±Π΅Π· ΠΏΠ½Π΅Π²ΠΌΠΎΠ½ΠΈΠΈΒ β Π²Β 24Β ΡΠ»ΡΡΠ°ΡΡ
(0,4Β %). Π Π΅ΡΡΠΎΡΠΏΠ΅ΠΊΡΠΈΠ²Π½ΠΎ ΡΒ ΡΡΠ΅ΡΠΎΠΌ ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΠΎΠΉ ΠΌΠΎΠ΄Π΅Π»ΠΈ ΠΊ Π³ΡΡΠΏΠΏΠ΅ Π²ΡΡΠΎΠΊΠΎΠ³ΠΎ ΡΠΈΡΠΊΠ° ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΏΠ½Π΅Π²ΠΌΠΎΠ½ΠΈΠΈ Π±ΡΠ»ΠΈ ΠΎΡΠ½Π΅ΡΠ΅Π½Ρ 933Β ΠΏΠ°ΡΠΈΠ΅Π½ΡΠ°, ΡΠ°ΡΡΠΎΡΠ° ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΏΠ½Π΅Π²ΠΌΠΎΠ½ΠΈΠΈ ΡΠΎΡΡΠ°Π²Π»ΡΠ»Π° 4,5Β %. ΠΒ Π³ΡΡΠΏΠΏΠ΅ Π½ΠΈΠ·ΠΊΠΎΠ³ΠΎ ΡΠΈΡΠΊΠ° ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΏΠ½Π΅Π²ΠΌΠΎΠ½ΠΈΠΈΒ β 5911Β ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ², ΡΠ°ΡΡΠΎΡΠ° ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΏΠ½Π΅Π²ΠΌΠΎΠ½ΠΈΠΈ ΡΠΎΡΡΠ°Π²Π»ΡΠ»Π° 0,19Β %. ΠΠ«ΠΠΠΠ«: ΠΡΡΠ²Π»Π΅Π½Ρ Π²ΠΎΡΠ΅ΠΌΡ Π½Π΅Π·Π°Π²ΠΈΡΠΈΠΌΡΡ
ΠΏΠ΅ΡΠ΅ΠΌΠ΅Π½Π½ΡΡ
, ΡΠ²ΡΠ·Π°Π½Π½ΡΡ
ΡΒ ΠΏΠΎΡΠ»Π΅ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠΉ ΠΏΠ½Π΅Π²ΠΌΠΎΠ½ΠΈΠ΅ΠΉ: Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΡ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΈ, ΠΊΡΡΠ΅Π½ΠΈΠ΅, ΠΏΠΎΠ»Π½Π°Ρ ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½Π°Ρ Π·Π°Π²ΠΈΡΠΈΠΌΠΎΡΡΡ, ΠΏΠ΅ΡΠΈΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½Π°Ρ Π°Π½Π΅ΠΌΠΈΡ, ΡΡΠ΅Π±ΡΡΡΠ°Ρ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ² ΠΆΠ΅Π»Π΅Π·Π°, ΠΈΠ½ΡΡΠ°ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠ΅ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ Π²Π°Π·ΠΎΠΏΡΠ΅ΡΡΠΎΡΠΎΠ², IIIΒ ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΡΠΉ ΠΊΠ»Π°ΡΡ ΠΏΠΎ ΠΊΠ»Π°ΡΡΠΈΡΠΈΠΊΠ°ΡΠΈΠΈ ΠΠΌΠ΅ΡΠΈΠΊΠ°Π½ΡΠΊΠΎΠ³ΠΎ ΠΎΠ±ΡΠ΅ΡΡΠ²Π° Π°Π½Π΅ΡΡΠ΅Π·ΠΈΠΎΠ»ΠΎΠ³ΠΎΠ², ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ Π±ΡΠΎΠ½Ρ
ΠΎΠ΄ΠΈΠ»Π°ΡΠΈΡΡΡΡΠΈΡ
ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ² ΠΏΠΎ ΠΏΠΎΠ²ΠΎΠ΄Ρ Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΎΠ±ΡΡΡΡΠΊΡΠΈΠ²Π½ΠΎΠΉ Π±ΠΎΠ»Π΅Π·Π½ΠΈ Π»Π΅Π³ΠΊΠΈΡ
, Π²ΡΡΠΎΠΊΠΈΠΉ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΡΠΉ ΡΠΈΡΠΊ. ΠΠΎΠ΄Π΅Π»Ρ ΠΏΡΠΎΠ³Π½ΠΎΠ·ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΏΠΎΡΠ»Π΅ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠΉ ΠΏΠ½Π΅Π²ΠΌΠΎΠ½ΠΈΠΈ ΠΈΠΌΠ΅Π΅Ρ ΠΎΡΠ»ΠΈΡΠ½ΡΡ ΠΏΡΠΎΠ³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΡΡ Π·Π½Π°ΡΠΈΠΌΠΎΡΡΡ (AUROCΒ =Β 0,904)
Recommended from our members
Firm-specific, country-specific and region-specific competitive advantages: the case of emerging economy MNEs - Thailand
Increasing levels of regional economic integration have created a new source of international competitiveness for MNEs from an emerging economy, Thailand, in the context of ASEAN economic integration. Building on the theoretical framework of firm-specific advantages (FSAs) and country-specific advantages (CSAs) grounded in internalization theory, we introduce region-specific advantages (RSAs) and advance a novel regional dual-double-diamond model to analyse regional competitiveness. Using both primary and secondary data we find that most Thai firms derive their international competitiveness from CSAs rather than FSAs, and will benefit from ASEAN RSAs. Our study significantly advances the literature on international competitiveness of emerging-economy MNEs
- β¦